Product Information
OTEZLA 20 MG TABLET is a brand product labeled by Amgen Inc., priced at $89.9522 per EA under NDC 55513049760. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
20 mg/1
Manufacturer
Amgen Inc.NDC
55513049760
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/7/2026
Active Ingredients
APREMILASTApproval Type
New Drug (NDA)
FDA Application
NDA205437On Market Since
4/25/2024
Pharmacological Classes
Price Statistics
The NADAC for OTEZLA 20 MG TABLET has been published 28 times since Dec 17, 2025, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $89.9522 per EA |
|---|---|
| All-time high | $89.9522 (Jun 24, 2026) |
| All-time low | $85.6687 (Dec 17, 2025) |
| 52-week high | $89.9522 |
| 52-week low | $85.6687 |
| Median price | $89.9522 |
| Average price | $89.3402 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the apremilast market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OTEZLA 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OTEZLA 20 MG TABLET, manufactured by Amgen Inc., is $89.9522 per EA (NDC 55513049760), effective Jun 24, 2026.
How has the price of OTEZLA 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for OTEZLA 20 MG TABLET has risen 5.0%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for OTEZLA 20 MG TABLET?
Since Dec 17, 2025, the NADAC for OTEZLA 20 MG TABLET has ranged from a low of $85.6687 (Dec 17, 2025) to a high of $89.9522 (Jun 24, 2026), with a median of $89.9522 per EA.
Are there cheaper alternatives to OTEZLA 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OTEZLA 20 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures OTEZLA 20 MG TABLET?
OTEZLA 20 MG TABLET (NDC 55513049760) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification